These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3594434)

  • 1. Development of an experimental model for studying bladder carcinogen metabolism using the isolated rat urinary bladder.
    Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
    Cancer Res; 1987 Jul; 47(14):3697-700. PubMed ID: 3594434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model for investigating bladder carcinogen metabolism using the isolated rat urinary bladder.
    Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
    IARC Sci Publ; 1987; (84):159-61. PubMed ID: 3679358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolism of bladder carcinogenic nitrosamines by rat liver and urothelial cells.
    Airoldi L; Magagnotti C; De Gregorio G; Moret M; Fanelli R
    Chem Biol Interact; 1992 Apr; 82(2):231-40. PubMed ID: 1568272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-oxidative metabolism of the bladder carcinogens N-nitrosobutyl(4-hydroxybutyl)amine and N-nitrosobutyl(3-carboxypropyl)amine within the rat isolated bladder.
    Airoldi L; Magagnotti C; Bonfanti M; Fanelli R
    Carcinogenesis; 1990 Aug; 11(8):1437-40. PubMed ID: 2387032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic profile and metabolism of N-nitrosobutyl-(4-hydroxybutyl)amine in rats.
    Bonfanti M; Magagnotti C; Bonati M; Fanelli R; Airoldi L
    Cancer Res; 1988 Jul; 48(13):3666-9. PubMed ID: 3378210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Nitrosobutyl(4-hydroxybutyl)amine alpha-hydroxylation by rat liver and urothelial cell homogenates.
    Airoldi L; Magagnotti C; Bonfanti M; Moret M; Fanelli R
    IARC Sci Publ; 1991; (105):343-5. PubMed ID: 1855877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of butylated hydroxyanisole on the metabolism of N-nitrosodi-n-butylamine and N-nitrosobutyl(4-hydroxybutyl)amine by rat hepatic S9 preparations in vitro.
    Pastorelli R; Ancidei A; Fanelli R; Airoldi L
    IARC Sci Publ; 1987; (84):183-4. PubMed ID: 3679366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine.
    Janzowski C; Jacob D; Henn I; Zankl H; Pool-Zobel BL; Wiessler M; Eisenbrand G
    IARC Sci Publ; 1991; (105):332-8. PubMed ID: 1855875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli infection of the urinary bladder: induction of tumours in rats receiving nitrosamine precursors and augmentation of bladder carcinogenesis by N-nitrosobutyl (4-hydroxybutyl)amine.
    Higgy NA; Verma AK; Ertürk E; Oberley TD; el-Aaser AA; el-Merzabani MM; Bryan GT
    IARC Sci Publ; 1987; (84):380-3. PubMed ID: 3315999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
    Suzuki E; Anjo T; Aoki J; Okada M
    Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder.
    Suzuki E; Iiyoshi M; Okada M
    Gan; 1981 Feb; 72(1):113-22. PubMed ID: 7274637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of O6-butyl- and O6-(4-hydroxybutyl)guanine in urothelial and hepatic DNA of rats given the bladder carcinogen N-nitrosobutyl(4-hydroxybutyl)amine.
    Airoldi L; Magagnotti C; Bonfanti M; Chiappetta L; Lolli M; Medana C; De Gregorio G; Fanelli R
    Carcinogenesis; 1994 Oct; 15(10):2297-301. PubMed ID: 7955070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal first-pass metabolism of nitrosamines. 2. Metabolism of N-nitrosodibutylamine in isolated perfused rat small intestinal segments.
    Richter E; Zwickenpflug W; Wiessler M
    Carcinogenesis; 1988 Mar; 9(3):499-506. PubMed ID: 3345589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
    Suzuki E; Okada M
    Gan; 1980 Dec; 71(6):856-62. PubMed ID: 7274630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fate of N-alkyl-N-(3-hydroxypropyl and 2-hydroxy-ethyl)nitrosamines in the rat in relation to the induction of bladder cancer by N-butyl-N-(4-hydroxybutyl)nitrosamine and its homologs.
    Suzuki E; Iiyoshi M; Okada M
    Gan; 1981 Apr; 72(2):254-8. PubMed ID: 7286549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
    Iida K; Itoh K; Maher JM; Kumagai Y; Oyasu R; Mori Y; Shimazui T; Akaza H; Yamamoto M
    Carcinogenesis; 2007 Nov; 28(11):2398-403. PubMed ID: 17602169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An experimental study on bladder carcinogenesis in dogs by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and its urinary metabolites].
    Morishita S; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):27-38. PubMed ID: 2729018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations on organ-specific metabolism and genotoxic effects of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine (BCPN) and its analogs N-nitrosodibutylamine (NDBA) and N-nitrosobutyl-4-hydroxybutylamine (4-OH-NDBA).
    Janzowski C; Jacob D; Henn I; Zankl H; Poole-Zobel BL; Eisenbrand G
    Toxicology; 1989 Dec; 59(2):195-209. PubMed ID: 2588266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
    Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M
    Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.